BOGGIANI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 870
AS - Asia 724
EU - Europa 408
SA - Sud America 123
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 1
Totale 2.205
Nazione #
US - Stati Uniti d'America 836
SG - Singapore 265
CN - Cina 172
VN - Vietnam 150
BR - Brasile 97
IE - Irlanda 96
SE - Svezia 70
IT - Italia 69
HK - Hong Kong 52
DE - Germania 43
ZA - Sudafrica 31
FR - Francia 28
GB - Regno Unito 22
NL - Olanda 20
BD - Bangladesh 18
IN - India 15
CA - Canada 14
AR - Argentina 13
RU - Federazione Russa 10
FI - Finlandia 9
IQ - Iraq 8
BE - Belgio 7
ES - Italia 7
AT - Austria 6
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
TR - Turchia 6
JP - Giappone 5
MX - Messico 5
PH - Filippine 5
PK - Pakistan 5
EG - Egitto 4
KR - Corea 4
LT - Lituania 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
ID - Indonesia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
PA - Panama 2
PL - Polonia 2
TN - Tunisia 2
UY - Uruguay 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MW - Malawi 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UA - Ucraina 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.179
Città #
Ashburn 160
Singapore 148
Dublin 95
Chandler 94
Santa Clara 71
San Jose 68
Beijing 54
Dallas 49
Hong Kong 48
Ho Chi Minh City 44
Hanoi 33
Boardman 30
Shanghai 30
Johannesburg 29
New York 23
Lauterbourg 18
Los Angeles 17
Council Bluffs 14
Bremen 13
Munich 12
Princeton 12
Seattle 12
Ann Arbor 11
Hefei 11
Parma 10
Phoenix 10
Brooklyn 9
Des Moines 9
Buffalo 8
Dearborn 8
Wilmington 8
Brussels 7
Da Nang 7
Frankfurt am Main 7
Helsinki 7
Ravenna 7
Abidjan 6
Haiphong 6
Rio de Janeiro 6
Denver 5
Montreal 5
Nuremberg 5
Olomouc 5
São Paulo 5
Ardea 4
Baghdad 4
Cascina 4
Moscow 4
Orem 4
Stockholm 4
Toronto 4
Verona 4
Amsterdam 3
Belo Horizonte 3
Biên Hòa 3
Bologna 3
Chicago 3
Columbus 3
Ha Long 3
Karachi 3
London 3
Manaus 3
Manchester 3
Mechanicsville 3
Rome 3
Seoul 3
Tokyo 3
Tây Ninh 3
Almaty 2
Aparecida de Goiânia 2
Aracaju 2
Atibaia 2
Atlanta 2
Bexley 2
Blumenau 2
Bogotá 2
Campinas 2
Can Tho 2
Chaguanas 2
Changsha 2
Chennai 2
Fairfield 2
Falls Church 2
Fremont 2
Giza 2
Huế 2
Hyderabad 2
Istanbul 2
Madrid 2
Managua 2
Marseille 2
Milan 2
Montevideo 2
Nairobi 2
Nanchang 2
Panama City 2
Pavia 2
Poplar 2
Praia Grande 2
Riga 2
Totale 1.380
Nome #
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 194
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 164
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 160
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 156
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 147
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 143
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 139
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 130
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 124
Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review 120
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 117
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations 115
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 114
Prognostic role of immunoglobulin g fragment c receptor polymorphisms in solid tumors 108
Risk of breast cancer in ovarian cancer patients non-carriers of BRCA1 and BRCA2 mutations with a family history of breast and ovarian cancer: A population-based cancer registry study 100
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2 positive breast cancers 93
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study 81
Totale 2.205
Categoria #
all - tutte 8.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 0 0 0 2 0 3 4 1 0 1 27
2022/2023315 25 34 19 22 34 33 2 23 112 1 8 2
2023/2024137 2 14 1 2 3 22 10 22 4 18 22 17
2024/2025435 23 20 25 29 46 40 17 23 55 47 34 76
2025/20261.021 110 107 125 102 111 67 90 35 129 88 26 31
2026/2027148 12 45 42 49 0 0 0 0 0 0 0 0
Totale 2.205